Sangamo Therapeutics (SGMO) Q2 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Next
Next
-0.11
-0.06
-0.01
0.04

Details

Expected EPS
-0.07365
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

Sangamo Therapeutics (SGMO) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts